Reduce (BAM, SLUPP322)

Laboratory and preclinical studies have documented the following research applications and observed effects:

Cellular Pathways Studied:

• Farnesoid X receptor (FXR) activation and downstream gene expression
• Takeda G-protein receptor 5 (TGR5) signaling mechanisms
• Hepatic lipid and glucose metabolism regulatory pathways
• Intestinal bile acid transport and homeostasis systems

Mechanisms of Action:

• Selective modulation of bile acid receptor subtypes
• Transcriptional regulation of metabolic genes through nuclear receptor activation
• Modulation of incretin hormone release in enteroendocrine cell models
• Influence on hepatic gluconeogenesis and lipogenesis pathways

Research Applications:

• Metabolic pathway investigation in hepatocyte and intestinal cell cultures
• Bile acid receptor pharmacology and selectivity studies
• Comparative analysis with natural bile acids and other synthetic analogs
• Mechanistic studies of metabolic disease pathways in cellular models

Experimental Models:

• In vitro: Primary hepatocytes, intestinal epithelial cells, transfected receptor cell lines
• Ex vivo: Liver slice cultures, intestinal tissue preparations
• In vivo: Laboratory animal models for metabolic and hepatic function studies
• Biochemical assays: Receptor binding assays, gene expression analysis, metabolite measurements

Research findings contribute to understanding bile acid receptor biology, metabolic regulation mechanisms, and potential therapeutic targets for metabolic disorders in controlled laboratory environments.